Florence Burté

Florence Burté

Auto-generated profile, based on publicly available information

Florence Burté

Institute for Regeneration and Repair, The University of Edinburgh, EH16 4UU, UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
BCBenjamin Cartes-Saavedra
Benjamin Cartes-Saavedra
DLDaniel Lagos
Daniel Lagos
JMJosefa Macuada
Josefa Macuada
DADuxan Arancibia
Duxan Arancibia
FBFlorence Burté
Florence Burté
VEVerónica Eisner
Verónica Eisner
Inner mitochondrial membrane fusion and cristae shape depend on optic atrophy protein 1, OPA1. Mutations in OPA1 lead to autosomal dominant optic atrophy (ADOA), an important cause of inherited blindness. The Guanosin Triphosphatase (GTPase) and GTPase effector domains (GEDs) of OPA1 are essential for mitochondrial fusion; yet, their specific roles remain elusive. Intriguingly, patients carrying OPA1 GTPase mutations have a higher risk of developing more severe multisystemic symptoms in addition to optic atrophy, suggesting pathogenic contributions for the GTPase and GED domains, respectively. We studied OPA1 GTPase and GED mutations to understand their domain-specific contribution to protein function by analyzing patient-derived cells and gain-of-function paradigms. Mitochondria from OPA1 GTPase (c.870+5G>A and c.889C>T) and GED (c.2713C>T and c.2818+5G>A) mutants display distinct aberrant cristae ultrastructure. While all OPA1 mutants inhibited mitochondrial fusion, some GTPase mutants resulted in elongated mitochondria, suggesting fission inhibition. We show that the GED is dispensable for fusion and OPA1 oligomer formation but necessary for GTPase activity. Finally, splicing defect mutants displayed a posttranslational haploinsufficiency-like phenotype but retained domain-specific dysfunctions. Thus, OPA1 domain-specific mutants result in distinct impairments in mitochondrial dynamics, providing insight into OPA1 function and its contribution to ADOA pathogenesis and severity.

22 April 2022 in American Journal of Ophthalmology
Verified
Journal Article
Open access
AMAnna Majander
Anna Majander
NJNeringa Jurkute
Neringa Jurkute
FBFlorence Burté
Florence Burté
KBKristian Brock
Kristian Brock
CJCatarina João
Catarina João
PYPatrick Yu-Wai-Man
Patrick Yu-Wai-Man
To evaluate the pattern of vision loss and genotype-phenotype correlations in WFS1-associated optic neuropathy (WON). Multicenter cohort study. The study involved 37 patients with WON carrying pathogenic or candidate pathogenic WFS1 variants. Genetic and clinical data were retrieved from the medical records. Thirteen patients underwent additional comprehensive ophthalmologic assessment. Deep phenotyping involved visual electrophysiology and advanced psychophysical testing with a complementary metabolomic study. WFS1 variants, functional and structural optic nerve and retinal parameters, and metabolomic profile. Twenty-two recessive and 5 dominant WFS1 variants were identified. Four variants were novel. All WFS1 variants caused loss of macular retinal ganglion cells (RGCs) as assessed by optical coherence tomography (OCT) and visual electrophysiology. Advanced psychophysical testing indicated involvement of the major RGC subpopulations. Modeling of vision loss showed an accelerated rate of deterioration with increasing age. Dominant WFS1 variants were associated with abnormal reflectivity of the outer plexiform layer (OPL) on OCT imaging. The dominant variants tended to cause less severe vision loss compared with recessive WFS1 variants, which resulted in more variable phenotypes ranging from isolated WON to severe multisystem disease depending on the WFS1 alleles. The metabolomic profile included markers seen in other neurodegenerative diseases and type 1 diabetes mellitus. WFS1 variants result in heterogenous phenotypes influenced by the mode of inheritance and the disease-causing alleles. Biallelic WFS1 variants cause more variable, but generally more severe, vision and RGC loss compared with heterozygous variants. Abnormal cleftlike lamination of the OPL is a distinctive OCT feature that strongly points toward dominant WON.

3 December 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SASamuel Eneọjọ Abah
Samuel Eneọjọ Abah
FBFlorence Burté
Florence Burté
SMSandrine Marquet
Sandrine Marquet
BBBiobele J. Brown
Biobele J. Brown
FAFrancis Akinkunmi
Francis Akinkunmi
DFDelmiro Fernandez-Reyes
Delmiro Fernandez-Reyes
Severe Malarial Anemia (SMA), a life-threatening childhood Plasmodium falciparum malaria syndrome requiring urgent blood transfusion, exhibits inflammatory and hemolytic pathology. Differentiating between hypo-haptoglobinemia due to hemolysis or that of genetic origin is key to understand SMA pathogenesis. We hypothesized that while malaria-induced hypo-haptoglobinemia should reverse at recovery, that of genetic etiology should not. We carried-out a case-control study of children living under hyper-endemic holoendemic malaria burden in the sub-Saharan metropolis of Ibadan, Nigeria. We show that hypo-haptoglobinemia is a risk factor for childhood SMA and not solely due to intravascular hemolysis from underlying schizogony. In children presenting with SMA, hypo-haptoglobinemia remains through convalescence to recovery suggesting a genetic cause. We identified a haptoglobin gene variant, rs12162087 (g.-1203G > A, frequency = 0.67), to be associated with plasma haptoglobin levels (p = 8.5 × 10−6). The Homo-Var:(AA) is associated with high plasma haptoglobin while the reference Homo-Ref:(GG) is associated with hypo-haptoglobinemia (p = 2.3 × 10−6). The variant is associated with SMA, with the most support for a risk effect for Homo-Ref genotype. Our insights on regulatory haptoglobin genotypes and hypo-haptoglobinemia suggest that haptoglobin screening could be part of risk-assessment algorithms to prevent rapid disease progression towards SMA in regions with no-access to urgent blood transfusion where SMA accounts for high childhood mortality rates.

6 January 2024 in EBioMedicine
Verified
Journal Article
Open access
SKSarah Kohe
Sarah Kohe
CBChristopher Bennett
Christopher Bennett
FBFlorence Burté
Florence Burté
MAMagretta Adiamah
Magretta Adiamah
HRHeather Rose
Heather Rose
APAndrew Peet
Andrew Peet
The malignant childhood brain tumour, medulloblastoma, is classified clinically into molecular groups which guide therapy. DNA-methylation profiling is the current classification 'gold-standard', typically delivered 3-4 weeks post-surgery. Pre-surgery non-invasive diagnostics thus offer significant potential to improve early diagnosis and clinical management. Here, we determine tumour metabolite profiles of the four medulloblastoma groups, assess their diagnostic utility using tumour tissue and potential for non-invasive diagnosis using in vivo magnetic resonance spectroscopy (MRS). Metabolite profiles were acquired by high-resolution magic-angle spinning NMR spectroscopy (MAS) from 86 medulloblastomas (from 59 male and 27 female patients), previously classified by DNA-methylation array (WNT (n = 9), SHH (n = 22), Group3 (n = 21), Group4 (n = 34)); RNA-seq data was available for sixty. Unsupervised class-discovery was performed and a support vector machine (SVM) constructed to assess diagnostic performance. The SVM classifier was adapted to use only metabolites (n = 10) routinely quantified from in vivo MRS data, and re-tested. Glutamate was assessed as a predictor of overall survival. Group-specific metabolite profiles were identified; tumours clustered with good concordance to their reference molecular group (93%). GABA was only detected in WNT, taurine was low in SHH and lipids were high in Group3. The tissue-based metabolite SVM classifier had a cross-validated accuracy of 89% (100% for WNT) and, adapted to use metabolites routinely quantified in vivo, gave a combined classification accuracy of 90% for SHH, Group3 and Group4. Glutamate predicted survival after incorporating known risk-factors (HR = 3.39, 95% CI 1.4-8.1, p = 0.025). Tissue metabolite profiles characterise medulloblastoma molecular groups. Their combination with machine learning can aid rapid diagnosis from tissue and potentially in vivo. Specific metabolites provide important information; GABA identifying WNT and glutamate conferring poor prognosis. Children with Cancer UK, Cancer Research UK, Children's Cancer North and a Newcastle University PhD studentship.

1 February 2020 in Biophysical Journal
Verified
Journal Article
Closed access
PDF file
BCBenjamin Cartes-Saavedra
Benjamin Cartes-Saavedra
DRDuxan Andres Arancibia Radich
Duxan Andres Arancibia Radich
FBFlorence Burté
Florence Burté
MSMarcela Sjoberg
Marcela Sjoberg
MAMaría Andrés
María Andrés
VEVerónica Eisner
Verónica Eisner

3 February 2026 in medRxiv
Verified
Preprint
Open access
PDF file
LFLeonie Fingerhut
Leonie Fingerhut
RVRamakrishnan Vigneshwar
Ramakrishnan Vigneshwar
FBFlorence Burté
Florence Burté
MDManojkumar Vimala Devi
Manojkumar Vimala Devi
RNRathinavel Sethu Nagarajan
Rathinavel Sethu Nagarajan
PLPrajna Lalitha
Prajna Lalitha
Objectives: Our primary objective was to identify the rate of anti-fungal resistance (including multidrug resistance) of fungal isolates cultured from fungal keratitis patients in South India. Our secondary objective was to identify associations between antifungal resistance and patient outcome. Subjects/Methods: 153 patients attending the cornea clinic at Aravind Eye Hospital, Madurai (May – August 2025) with culture positive fungal keratitis were enrolled in the study. Cultured isolates were evaluated for natamycin, amphotericin B, voriconazole and econazole MIC (n=151-153). MIC data were analysed by Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Patient disease outcome relative to isolate resistance was analysed by fisher’s exact test (n=91). Results: There were high levels of resistance to all four antifungals, which were significantly elevated in Fusarium spp. and Aspergillus spp. isolates compared to other fungal genera (P<0.0001). Resistance of Fusarium spp. isolates (n= 81) to: natamycin: 38.3%; amphotericin B: 93.8%; voriconazole: 97.5% and econazole: 76.5%. Resistance of Aspergillus spp. isolates (n=33) to: natamycin: 66.7%; amphotericin B: 87.9%; voriconazole: 6.1%; and econazole: 0%. Overall, fungal resistance to natamycin significantly correlated with a poor clinical outcome, P=0.0034, relative risk 1.7 (95% CI: 1.2-2.6). Conclusions: The majority of fungal isolates were resistant to multiple antifungals; none of the Fusarium isolates were susceptible to all four drugs, 15% were resistant to all of them. Resistance towards natamycin may worsen clinical outcome, particularly for infections caused by Aspergillus , even when susceptible to azoles. Our data supports the need for species specific MIC thresholds to have increased clinical utility.